ObsEva SA. EBIT

The latest EBIT for OBSV is $-35M as of December 2022. That compares with $-55M in the prior-year period — up 37.1% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside ObsEva SA.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, OBSV's EBIT moved from $-55M to $-35M — a 37.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ObsEva SA.'s operating scale or balance-sheet position.

Against Healthcare companies, OBSV currently prints $-35M for EBIT, while the sector average sits near $23B. That is roughly 100.2% below the sector mean. Large gaps often invite a closer look at ObsEva SA.'s growth, margins, and balance sheet.

A EBIT figure of $-35M for OBSV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.

After noting OBSV's EBIT ($-35M), review year-over-year change from $-55M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.